Kemofarmacija
Kemofarmacija is a Slovenian pharmaceutical wholesaler distributing medicinal products and medical devices to over 1,100 pharmacies, hospitals, health centres, veterinarians, and specialised stores nationwide, operating the Elona B2B portal and logistics infrastructure under majority PHOENIX group ownership.
- Company typePrivate
- Founded1947
- HeadquartersLjubljana, Slovenia
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Kemofarmacija does
Kemofarmacija d.d. is a Slovenian pharmaceutical wholesaler founded in 1947 and headquartered in Ljubljana, currently operating as a privately held subsidiary of Germany's PHOENIX group. The company distributes medicinal products, medical devices, food supplements, cosmetics, and other healthcare products to over 1,100 B2B customers across Slovenia, including all public and hospital pharmacies, most community health centres, veterinarians, and specialised stores. All operations route through a single 6,000+ m² distribution and warehousing centre in Ljubljana that meets Good Distribution Practice (GDP) standards, with 100% national coverage achieved through in-house and contracted delivery fleets executing 80,000 deliveries per year over 1.3 million kilometres.
The company's core technology stack centres on two integrated B2B web portals: Elona for pharmacy customers and eNabava for suppliers, both connected to a centralised warehouse management system. Over 90% of orders are received electronically through Elona, over 28% of orders are prepared automatically by the warehousing system, and the platform processes more than 450 orders per day while customer service handles over 700 calls daily. Supporting assets include FarmaPro, a 24/7 online professional education platform for doctors and pharmacists, plus FarmaInfo, Receptum, eNovice, and eReceptum content channels providing professional information to pharmacy customers. Kemofarmacija operates as a member of PHOENIX group, the European pharmaceutical wholesale leader present in 29 markets with over 45,000 employees globally.
Revenue is generated primarily through B2B pharmaceutical wholesale distribution on a transactional basis, with prices typically listed without VAT. Free delivery applies to contract customers on orders of €500 or more, with a €7 handling fee below that threshold, and payment terms of 8 days or per contract. Secondary revenue streams include contract logistics and warehousing services (consignment, customs, contractual storage), transportation services across Slovenia, and contract secondary packaging and manufacturing of medicines for pharmaceutical suppliers, including clinical-trial support and import of unregistered medicines. The company does not publicly disclose revenue, is owned with majority foreign ownership through PHOENIX group, and operates from a single-country domestic footprint with no disclosed expansion beyond Slovenia.
Kemofarmacija firmographics
Firmographics- Name
- Kemofarmacija
- Legal name
- Kemofarmacija d.d.
- Website
- https://kemofarmacija.si
- Company type
- Private
- Founded year
- 1947
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Kemofarmacija is a Slovenian pharmaceutical wholesaler distributing medicinal products and medical devices to over 1,100 pharmacies, hospitals, health centres, veterinarians, and specialised stores nationwide, operating the Elona B2B portal and logistics infrastructure under majority PHOENIX group ownership.
- Ownership category
- akta.pro rank
Kemofarmacija industry classification
Industry- Product category
- Pharmaceutical Wholesale Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)
Keywords
Where Kemofarmacija is headquartered
LocationHeadquarters
- HQ city
- Ljubljana
- HQ country
- Slovenia
- HQ region
- Europe
Offices2 records
Markets served
Kemofarmacija business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Wholesale Distribution: Core revenue stream from distribution of medicinal products, medical devices, and other healthcare products to pharmacies, hospitals, health centres, and other partners. The company operates as a wholesale trader providing reliable, safe, timely, and comprehensive supply.
- Logistics and Warehousing Services: Storage and logistics services including warehousing in various warehouse types (consignment, customs, contractual) for medicinal products, medical devices and other products, transport services, and secondary packaging/manufacturing of medicines.
- Marketing and Information Services: Additional services including FarmaInfo newsletter, Receptum supplement, and various marketing services for pharmaceutical companies and other suppliers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Standard wholesale pricing with free delivery threshold |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Kemofarmacija product offering
Product offeringCore offering
Kemofarmacija is a B2B wholesaler of medicinal products and medical devices distributing pharmaceutical, health, cosmetic, and chemical products from over 350 suppliers through its Ljubljana distribution centre to pharmacies, hospitals, health centres, veterinarians and specialised stores across Slovenia. The company also provides contract logistics, warehousing (consignment, customs, contractual), transport, and secondary packaging of medicines for pharmaceutical manufacturers, supported by the Elona B2B portal for electronic ordering.
Product overview
Kemofarmacija offers a comprehensive pharmaceutical wholesale and logistics platform built around its core Elona B2B ordering portal for pharmacies. The platform is complemented by the eNabava supplier portal, both connected for streamlined business processes. Supporting services include FarmaInfo and Receptum (monthly newsletters with professional content for pharmacists), FarmaPro (24/7 online professional education), and eNovice/eReceptum (electronic versions). Core services encompass wholesale distribution of medicinal products, warehousing meeting GDP standards, transport services covering all of Slovenia, and secondary packaging/manufacturing of medicines. Over 90% of orders are received electronically through these digital channels, serving over 1,100 pharmacy customers with access to over 11,500 products from 350+ suppliers.
Differentiator
Problem solved
Functional benefit
Brands
- Elona: Online customer portal for ordering pharmaceutical products and communication with customers
- FarmaPro
- FarmaInfo
- Receptum
Products and services
- Pharmaceutical Wholesale Distribution B2B distribution of medicinal products, medical devices, food supplements, cosmetics, and chemical products from over 350 suppliers to pharmacies, hospitals, health centres, veterinarians and specialised stores throughout Slovenia, with 100% national coverage, 80,000 annual deliveries, and the broad product portfolio of over 11,500 SKUs in stock.
- Warehousing Services Storage services offered in various warehouse types — consignment warehouse, customs warehouse, and contractual warehouse — for medicinal products, medical devices and other products, meeting safety, temperature, and GDP requirements across over 6,000 m2 of warehouse space.
- Transport Services Secure and reliable transportation services for pharmaceutical and healthcare products covering the entire territory of Slovenia, with approximately 1.3 million kilometres covered per year and 80,000 deliveries per year to customers.
- Manufacturing and Secondary Packaging of Medicines and Other Products Production and secondary packaging services for medicines and other products following special procedures, including the receiving and issuing of clinical trial medicinal products, offered as a contract manufacturing service to pharmaceutical companies.
- Import of Unregistered Medicines Entry and import service for unregistered medicines into Slovenia, enabling pharmaceutical companies to supply investigational or unauthorised medicinal products for clinical trials and special patient access situations.
Quantifiable outcome
- Over 90% of orders received electronically
- +6 more outcomes
Companies that use Kemofarmacija
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Kemofarmacija technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Kemofarmacija partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PHOENIX GroupcoreKemofarmacija is a member of PHOENIX group, the European leader in pharmaceutical wholesale, pharmacy retail, and services for the pharmaceutical industry. With presence in 29 European healthcare markets and over 45,000 employees, PHOENIX group provides the backing and best practices for Kemofarmacija's operations in Slovenia. The group is headquartered in Mannheim and brings experience from other European markets to Slovenia.
Scale indicators12 records
Recent moves6 records
Expansion highlights5 records
Kemofarmacija competitors and assessment
Company assessmentDirect peers
- Phoenix Pharma Hungary: Hungarian national pharmaceutical wholesale subsidiary of PHOENIX group. Direct sibling to Kemofarmacija within the PHOENIX network; highly comparable national pharma wholesale operations and customer profiles.
- Phoenix Pharma Polska: Polish pharmaceutical wholesale subsidiary of PHOENIX group. Sibling entity to Kemofarmacija with the same wholesale operating model, supplier base, and customer profile within a national market.
- Tamro (PHOENIX Baltics): PHOENIX-owned pharmaceutical wholesaler serving Estonia, Latvia, and Lithuania. Closest direct peer to Kemofarmacija — same parent, same pharma wholesale model, same B2B portal-based distribution to pharmacies and hospitals, just on a different national geography.
Broad incumbents
- Stada Arzneimittel: European pharmaceutical manufacturer and distributor (generics and consumer health) with bundled distribution capabilities. Comparable European pharma value-chain positioning — a supplier-side peer whose commercial terms and product strategy directly influence Kemofarmacija's wholesale economics.
- Alliance Healthcare: Walgreens Boots Alliance-owned European pharmaceutical wholesaler operating across multiple EU countries. Comparable breadth of pharma distribution plus value-added services to community pharmacies and hospitals — a leading European incumbent in the same category as Kemofarmacija.
- Krka: Slovenian-headquartered generic pharmaceutical manufacturer supplying through Kemofarmacija. Comparable Slovenian healthcare ecosystem presence; as a major pharma manufacturer partner, useful proxy for downstream demand and supplier-power dynamics affecting Kemofarmacija's wholesale business.
- PHOENIX Group AG: Parent company of Kemofarmacija and the European leader in pharmaceutical wholesale, pharmacy retail, and pharma industry services across 29 markets. Directly comparable business model and customer base at group level; Kemofarmacija operates as its Slovenian national wholesale subsidiary.
- Celesio / McKesson Europe: Major European pharmaceutical wholesale and pharmacy retail network (formerly Celesio, now part of McKesson). Comparable wholesale distribution plus retail pharmacy model serving European healthcare markets.
Regional players
- Medis (Slovenia): Slovenian pharmaceutical distribution and marketing company covering medicinal products, medical devices, and consumer health. Operates in the same Slovenian market with overlapping supplier relationships and complementary distribution activities.
- Salus (Slovenia): Slovenian pharmacy retail network and parallel importer. Operates alongside Kemofarmacija in the Slovenian pharmaceutical value chain — part customer, part adjacent competitor in parallel import activities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Kemofarmacija social profiles
Digital presenceKemofarmacija financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kemofarmacija leadership team
Management profileNumber of profiles
Kemofarmacija funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kemofarmacija M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kemofarmacija
What does Kemofarmacija do?
Kemofarmacija is a B2B wholesaler of medicinal products and medical devices distributing pharmaceutical, health, cosmetic, and chemical products from over 350 suppliers through its Ljubljana distribution centre to pharmacies, hospitals, health centres, veterinarians and specialised stores across Slovenia. The company also provides contract logistics, warehousing (consignment, customs, contractual), transport, and secondary packaging of medicines for pharmaceutical manufacturers, supported by the Elona B2B portal for electronic ordering.
Is Kemofarmacija a public or private company?
Kemofarmacija is a private company. It is classified as corporate owned and is currently operating.
When was Kemofarmacija founded?
Kemofarmacija was founded in 1947. It employs 101 to 250 people.
Where is Kemofarmacija based?
Kemofarmacija is headquartered in Ljubljana, Slovenia, in the Europe region.
How does Kemofarmacija make money?
Three revenue lines are on record. Pharmaceutical Wholesale Distribution is the primary driver. The others are logistics and Warehousing Services and marketing and Information Services.
Who are Kemofarmacija's main competitors?
Direct peers on record are Phoenix Pharma Hungary, Phoenix Pharma Polska and Tamro (PHOENIX Baltics). Broad incumbents are Stada Arzneimittel, Alliance Healthcare, Krka, PHOENIX Group AG and Celesio / McKesson Europe. Regional players are Medis (Slovenia) and Salus (Slovenia).
Does Kemofarmacija have an API?
No public API is recorded for Kemofarmacija.
What industry is Kemofarmacija in?
Kemofarmacija's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is HLAIAJAK, Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers. Its NAICS code is 42421 and its SIC code is 5122.